American Oriental Bioengineering Inc - ESG Rating & Company Profile powered by AI
The ESG assessment for American Oriental Bioengineering Inc represents the company's reporting of the United Nations Sustainable Development Goals. This analysis of American Oriental Bioengineering Inc incorporates data from across the internet and also from public disclosures by American Oriental Bioengineering Inc. Alternative corporations in the scoring industry group for American Oriental Bioengineering Inc are displayed below.
American Oriental Bioengineering Inc in the Personal Products industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | AKD SA | 8.0 | High |
1 | Kao Corp | 8.0 | High |
... | ... | ... | |
221 | Bon Fame Co Ltd | 0.5 | Low |
222 | AmorePacific Corp | 0.4 | Low |
223 | American Oriental Bioengineering Inc | 0.0 | Low |
223 | CTK Co Ltd | 0.0 | Low |
223 | CKH Food & Health Ltd | 0.0 | Low |
223 | Zhejiang Shouxiangu Pharmaceutical Co Ltd | 0.0 | Low |
223 | iPure Labs Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does American Oriental Bioengineering Inc have an accelerator or VC vehicle to help deliver innovation?
Does American Oriental Bioengineering Inc disclose current and historical energy intensity?
Does American Oriental Bioengineering Inc report the average age of the workforce?
Does American Oriental Bioengineering Inc reference operational or capital allocation in relation to climate change?
Does American Oriental Bioengineering Inc disclose its ethnicity pay gap?
Does American Oriental Bioengineering Inc disclose cybersecurity risks?
Does American Oriental Bioengineering Inc offer flexible work?
Does American Oriental Bioengineering Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does American Oriental Bioengineering Inc disclose the number of employees in R&D functions?
Does American Oriental Bioengineering Inc conduct supply chain audits?
Does American Oriental Bioengineering Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does American Oriental Bioengineering Inc conduct 360 degree staff reviews?
Does American Oriental Bioengineering Inc disclose the individual responsible for D&I?
Does American Oriental Bioengineering Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does American Oriental Bioengineering Inc disclose current and / or historical scope 2 emissions?
Does American Oriental Bioengineering Inc disclose water use targets?
Does American Oriental Bioengineering Inc have careers partnerships with academic institutions?
Did American Oriental Bioengineering Inc have a product recall in the last two years?
Does American Oriental Bioengineering Inc disclose incidents of discrimination?
Does American Oriental Bioengineering Inc allow for Work Councils/Collective Agreements to be formed?
Has American Oriental Bioengineering Inc issued a profit warning in the past 24 months?
Does American Oriental Bioengineering Inc disclose parental leave metrics?
Does American Oriental Bioengineering Inc disclose climate scenario or pathway analysis?
Does American Oriental Bioengineering Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does American Oriental Bioengineering Inc disclose the pay ratio of women to men?
Does American Oriental Bioengineering Inc support suppliers with sustainability related research and development?
Does American Oriental Bioengineering Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does American Oriental Bioengineering Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is American Oriental Bioengineering Inc involved in embryonic stem cell research?
Does American Oriental Bioengineering Inc disclose GHG and Air Emissions intensity?
Does American Oriental Bioengineering Inc disclose its waste policy?
Does American Oriental Bioengineering Inc report according to TCFD requirements?
Does American Oriental Bioengineering Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does American Oriental Bioengineering Inc disclose energy use targets?
Does American Oriental Bioengineering Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does American Oriental Bioengineering Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for American Oriental Bioengineering Inc
These potential risks are based on the size, segment and geographies of the company.
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.